Mirati Therapeutics, Inc.
MRTXDelisted Jan 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001576263
Mirati Therapeutics, Inc. was delisted on Jan 23, 2024; its insiders filed their last Form 4 on Jan 25, 2024; 218 institutions reported holding it in 13F filings for Q4 2023, worth $4.66B in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Mirati Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 215
- +10 vs. Q2 2023
- Shares held
- 81.0M
- +15.2M (+23.1%) vs. Q2 2023
- Total value
- $3.53B
- +$1.15B (+48.4%) vs. Q2 2023
- New holders
- 46
- 94 more added
- Sold out
- 36
- 51 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $2.52K |
| Q4 2023 | 218 | $4.66B |
| Q3 2023 | 215 | $3.53B |
| Q2 2023 | 207 | $2.38B |
| Q1 2023 | 222 | $2.38B |
| Q4 2022 | 233 | $2.97B |
| Q3 2022 | 243 | $4.44B |
| Q2 2022 | 231 | $4.21B |
| Q1 2022 | 252 | $4.71B |
| Q4 2021 | 260 | $8.34B |
| Q3 2021 | 239 | $9.59B |
| Q2 2021 | 245 | $8.57B |
| Q1 2021 | 260 | $9.16B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Mirati Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 1,668,116 | $72.7M | 4.96% | +224,354+15.5% | Added |
| Assenagon Asset Management S.A. | 1,825,678 | $79.5M | 0.28% | +1,016,858+125.7% | Added |
| OrbiMed Advisors LLC | 1,959,050 | $85.3M | 1.97% | +1,045,400+114.4% | Added |
| Artal Group S.A. | 2,024,226 | $88.2M | 3.84% | −30,955−1.5% | Reduced |
| Price T Rowe Associates Inc | 2,433,029 | $106.0M | 0.02% | +655,450+36.9% | Added |
| Morgan Stanley | 2,462,132 | $107.3M | 0.01% | −382,340−13.4% | Reduced |
| State Street Corp | 2,745,968 | $119.6M | 0.01% | +164,229+6.4% | Added |
| Aviva Holdings Ltd. | 3,135,966 | $136.6M | 87.83% | 00.0% | Unchanged |
| Boxer Capital, LLC | 3,201,440 | $139.5M | 7.42% | +1,201,440+60.1% | Added |
| Wellington Management Group LLP | 3,319,922 | $144.6M | 0.03% | −68,443−2.0% | Reduced |
| BlackRock Inc. | 3,544,311 | $154.4M | 0.00% | +226,292+6.8% | Added |
| Vanguard Group Inc | 5,699,632 | $248.3M | 0.01% | +721,357+14.5% | Added |
| EcoR1 Capital, LLC | 5,748,399 | $250.4M | 8.53% | +5,748,399 | New |
| Avoro Capital Advisors LLC | 6,666,666 | $290.4M | 4.53% | +1,111,111+20.0% | Added |
| RTW Investments, LP | 6,768,514 | $294.8M | 6.22% | +2,295,529+51.3% | Added |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −719,103−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −240,625−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −195,320−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −184,060−100.0% | Sold out |
| Oracle Investment Management Inc | 0 | $0 | 0.00% | −152,600−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −98,500−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −89,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −73,276−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −69,454−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −51,988−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −44,302−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −39,564−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −24,201−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,840−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −15,738−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −13,207−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −12,680−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −10,636−100.0% | Sold out |
| Crystalline Management Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Connacht Asset Management LP | 0 | $0 | 0.00% | −6,798−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −6,652−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −6,466−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −6,367−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,350−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −4,178−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Pinebridge Investments, L.P. | 0 | $0 | 0.00% | −2,336−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −1,434−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −676−100.0% | Sold out |
| Evermay Wealth Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |
| Kistler-Tiffany Companies, LLC | – | – | – | – | Not filed |